title: Posttransplant hypertension: multipathogenic disease process.
abstract: Arterial hypertension is prevalent among kidney transplant recipients. The multifactorial pathogenesis involves the interaction of the donor and the recipient's genetic backgrounds with several environmental parameters that may precede or follow the transplant procedure (eg, the nature of the renal disease, the duration of the chronic kidney disease phase and maintenance dialytic therapy, the commonly associated cardiovascular disease with atherosclerosis and arteriosclerosis, the renal mass at implantation, the immunosuppressive regimen used, life of the graft, and de novo medical and surgical complications that may occur after a transplant). Among calcineurin inhibitors, tacrolimus seems to have a better cardiovascular profile. Steroid-free protocols and calcineurin inhibitor-free regimens seem to be associated with better blood pressure control. Posttransplant hypertension is a major amplifier of the chronic kidney disease-cardiovascular disease continuum. Despite the adverse effects of hypertension on graft and patient survival, blood pressure control remains poor because of the high cardiovascular risk profile of the donor-recipient pair. Although the optimal blood pressure level remains unknown, it is recommended to maintain the blood pressure at < 130/80 mm Hg and < 125/75 mm Hg in the absence or presence of proteinuria.
authors.affiliation: Renal Transplantation Unit, Rafik Hariri University Hospital, Bir Hassan, Beirut-Lebanon. barbariantoine@gmail.com
authors.forename: Antoine
authors.initials: A
authors.lastname: Barbari
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D006084:Graft Rejection / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D006977:Hypertension, Renal / Q000188:drug therapy* / Q000453:epidemiology; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000706:statistics & numerical data; D011183:Postoperative Complications / Q000188:drug therapy* / Q000453:epidemiology; D015995:Prevalence
chemical_list: D000959:Antihypertensive Agents; D007166:Immunosuppressive Agents